Sr. Director - TS/MS (NOT REMOTE - NEW SITE) at Eli Lilly and Company

Chester, Maryland, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Candidates must possess a PhD in a relevant science or engineering discipline, preferably Chemistry or Biochemistry, and have over 10 years of leadership experience in pharmaceutical manufacturing operations. A deep understanding of cGMPs, strong relationship-building skills across all organizational levels, and experience leading high-performing teams are essential. The role requires relocation to the new site area, with initial remote work and occasional travel to Indianapolis.

Responsibilities

The Senior Director of Technical Services/Manufacturing Science will lead the site's TS/MS function, overseeing small molecule, oligonucleotide manufacturing, and laboratory operations. This includes shaping site strategy, managing new product introductions, process development, optimization, and ensuring cGMP and regulatory compliance. The role involves collaborating with development teams, governing CMOs, contributing to business planning, and developing personnel within the TS/MS department.

Skills

Technical Leadership

Manufacturing Science

Small Molecule Manufacturing

Oligonucleotide Manufacturing

API Manufacturing

GMP Manufacturing

Site Strategy

Organizational Capability

Cross-functional Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free